Unlocking Clinical Trial Recruitment Success: Bionews Presents at World Orphan Drug Congress 2024
The session will highlight how Bionews’ large reach and access among rare disease patients, combined with strong community activation expertise and a patient-centric approach, accelerates trial recruitment programs. During the presentation, Bionews also will share key...
Bionews announces poster win in trial methodology category at 2023 CNS Summit
Winning poster presentation highlights company’s accelerated ability to connect patient communities with clinical trials.
Bionews empowers Friedreich’s Ataxia community with inaugural live webinar
Panel of experts and patients provided tips on management, treatment, and financial planning for Friedreich’s Ataxia patients and caregivers.
Bionews Unveils New Brand Identity for Websites Highlighting Patient-centric Mission
Bionews Inc. unveiled new branding across each of its 68 owned and operated media websites in the rare and chronic disease space. This effort includes a logo suite and visual identity for each website and establishment of Bionews as the global parent company.
Bionews Staff Writer Hawken Miller 1 of 25 Selected for Prestigious Rare Disease Journalism Fellowship From National Press Foundation
Bionews announced today that Hawken Miller, a staff writer and columnist on its website Muscular Dystrophy News Today, is the recipient of a Rare Disease Journalism Fellowship by the National Press Foundation (NPF).